Login      Sign-Up  
Skip Navigation Links
Home
Laws
Bills
Sessions
House
Senate
Committees
Legislators
My Legis
2025 First Extraordinary Session
Other Sessions
Scroll up
Scroll down
2025 First Extraordinary Session
Other Sessions
Scroll up
Scroll down
House Committees
Senate Committees
Miscellaneous Committees
Scheduled Meetings
Scroll up
Scroll down
Representatives
Senators
Caucuses and Delegations
Scroll up
Scroll down

2024 Regular Session
SB224   by Senator Robert "Bob" Owen      

PHARMACEUTICALS:  Provides relative to opioid alternatives. (8/1/24) (EN NO IMPACT See Note)

Current Status:  Signed by the Governor - Act 320


Skip Navigation Links
TextExpand Text
AmendmentsExpand Amendments
DigestsExpand Digests
NotesExpand Notes
VotesExpand Votes
AuthorsExpand Authors
SB224 Act 320
SB224 Enrolled
SB224 Engrossed
SB224 Original
Scroll up
Scroll down
Senate Committee Amendment #2464 H&W Adopted
Senate Committee Amendment #1125 H&W Draft
Scroll up
Scroll down
Resume Digest for SB224
Digest of SB224 Engrossed
Digest of SB224 Original
Scroll up
Scroll down
Fiscal Note - SB224 Enrolled
Fiscal Note - SB224 Engrossed
Fiscal Note - SB224 Original
Scroll up
Scroll down
House Vote on SB 224 FINAL PASSAGE (#1320)
Senate Vote on SB 224 FINAL PASSAGE (#486)
Scroll up
Scroll down
Robert "Bob" Owen (primary)
Scroll up
Scroll down

 Date   ChamberJournal
Page
Action sort history by ascending dates
05/28S  Effective date 8/1/2024.
05/28S  Signed by the Governor. Becomes Act No. 320.
05/28S84  Sent to the Governor by the Secretary of the Senate on 5/23/2024.
05/23H1  Signed by the Speaker of the House.
05/23S102  Enrolled. Signed by the President of the Senate.
05/22S39  Received from the House without amendments.
05/22H54  Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, ordered to the Senate.
05/21H  Scheduled for floor debate on 05/22/2024.
05/21H8  Read by title, passed to 3rd reading.
05/20H15  Reported without Legislative Bureau amendments.
05/15H45  Reported favorably (11-0). Referred to the Legislative Bureau.
05/07H5  Read by title, under the rules, referred to the Committee on Health and Welfare.
05/06H2  Received in the House from the Senate, read by title, lies over under the rules.
05/01S25  Read by title, passed by a vote of 39 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.
04/30S38  Read by title and passed to third reading and final passage.
04/30S37  Rules suspended. Recalled from Committee.
04/29S13  Read by title. Committee amendments read and adopted; ordered engrossed and recommitted to the Committee on Finance.
04/24S8  Reported with amendments.
03/11S23  Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Health and Welfare.
03/01S  Prefiled and under the rules provisionally referred to the Committee on Health and Welfare.




If you experience any technical difficulties navigating this website, contact the webmaster.
P.O. Box 94062 (900 North Third Street) Baton Rouge, Louisiana 70804-9062